
Millions of children at risk from stalling global vaccinations, study says
The study said that while global coverage for key vaccines, including those against measles, polio, and tuberculosis, almost doubled between 1980 and 2023, progress slowed in many countries and territories between 2010 and 2019, and has even reversed in some cases in recent years.
Advertisement
The trend was also seen in wealthier parts of the world, with declines in at least one
key
vaccine in 21 of 36 high-income countries and territories.
The coronavirus pandemic 'exacerbated these challenges, with global rates for these vaccines declining sharply since 2020, and still not returning to pre-COVID-19 pandemic levels as of 2023,' the study said, causing tens millions of children to miss doses of routine vaccines and 'increasing their risk for preventable disease and death.'
'Despite the monumental efforts of the past 50 years, progress has been far from universal. Large numbers of children remain under- and un-vaccinated,' senior study author Jonathan Mosser of University of Washington's Institute for Health Metrics and Evaluation said in a news release.
Advertisement
'Routine childhood vaccinations are among the most powerful and cost-effective public health interventions available, but persistent global inequalities, challenges from the COVID pandemic, and the growth of vaccine misinformation and hesitancy have all contributed to faltering immunization progress,' he added.
In many countries, these trends have led to outbreaks of diseases that can be prevented by vaccination, such as measles, polio, and diphtheria, the study said.
Kate O'Brien, WHO director for immunization, vaccines, and biologicals, said in an emailed statement that 'despite incredible progress' brought about by vaccines, 'we are now confronting a painful reality: Progress has stalled and in some countries is being lost. Immunization rates have plateaued, and year after year, we are reaching the same proportion of children without extending their reach to those left behind.'
'Unless we intensify efforts to reach more children through equitable routine immunization programmes, increase domestic investment, and strengthen vaccine confidence and demand, we risk undoing years of hard-won progress — leading to a future where more children suffer from preventable illnesses and premature death,' she added.
An increase in vaccine hesitancy, as well as misinformation — which the WHO signaled as a leading threat to global public health even before the pandemic — have impacted immunization, the study noted. Conflict is another factor. The outbreak of civil war in Sudan in 2023 led to one key coverage measurement — the number of children receiving the first dose of the DTP vaccine against diphtheria, tetanus, and pertussis — falling from almost 90 percent to about half of that, according to the study.
Planned budget cuts to vaccines 'are likely to disproportionately affect low-income and middle income countries,' the study said, but richer countries are also likely to be affected by higher costs caused by increasing outbreaks.
Advertisement
The study's findings echo a warning this spring from the head of the World Health Organization, Tedros Adhanom Ghebreyesus, who noted outbreaks of vaccine-preventable diseases were increasing around the world, 'putting lives at risk and exposing countries to increased costs in treating diseases and responding to outbreaks.' He urged countries with limited resources to 'invest in the highest-impact interventions — and that includes vaccines.'
The study, which was funded by the Bill & Melinda Gates Foundation and Gavi, the Vaccine Alliance, was published in the Lancet medical journal. Last month, Health and Human Services Secretary Robert F. Kennedy Jr. said he may stop government scientists from publishing in the Lancet and several other top peer-reviewed journals, accusing them — without evidence — of being 'corrupt.'
Shortly after returning to office in January, President Trump announced the United States' withdrawal from the WHO. Two months later, a USAID document showed that the administration planned funding cuts for Gavi, which provides lifesaving vaccinations for millions of people in the world's poorest countries.
Domestically, following the deaths of two children in Texas from measles — with a total of 23 outbreaks recorded across the US with more than 1,000 confirmed cases — Kennedy has given mixed messages on measles immunization and caused controversy by announcing placebo testing for new vaccines.
David L. Heymann, professor of infectious-disease epidemiology at the London School of Hygiene and Tropical Medicine, and who was not involved in the research, said in a telephone interview Wednesday that public trust is a key part of vaccination success.
He urged governments to 'take a great interest in this and to make sure that they're getting the right messages to their people,' and emphasized the importance of evidence-based recommendations from trusted organizations like the US Centers for Disease Control and Prevention.
Advertisement
Professor Andrew Pollard, director of the Oxford Vaccine Group and a professor at the University of Oxford, who also was not involved in the research, in a statement called the findings a 'worrying trend' that is 'set to deteriorate' amid global health funding cuts.
In a separate email Wednesday, he accused the Trump administration of 'undermining' parents' confidence in vaccines, risking further drops in coverage.
'This combined with a catastrophic reduction of global health funding, rejection of scientific evidence on vaccines and challenges to credible scientific leadership on immunisation policy means that the once trusted voice of America on vaccines is diminished,' he said.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time Business News
13 hours ago
- Time Business News
Child Growth Chart Calculator UK – Track Your Child's Development Percentile
It's natural to wonder if your child is growing as expected. Thankfully, growth charts make it easy to track development and spot any concerns early. The Child Growth Chart Calculator UK allows parents to compare their child's stats against NHS and WHO growth standards — providing peace of mind and professional-grade accuracy. Child Growth Chart Calculator UK systems have become increasingly sophisticated, thanks to evidence-based tools developed by leading pediatric organizations. The Royal College of Paediatrics and Child Health (RCPCH) provides comprehensive growth charts that healthcare professionals and parents can use to track development from birth through adolescence. A reliable Child Growth Chart Calculator UK uses WHO (World Health Organisation) growth standards, which describe optimal growth patterns for healthy, breastfed children. These calculators are available in two main categories: UK-WHO growth charts for 0-4 years and UK-WHO growth charts for 2-18 years, ensuring continuous monitoring throughout childhood and adolescence. Centile charts (also called percentile charts) are fundamental tools that pediatricians use to assess whether a child's growth falls within expected ranges. These charts don't simply tell you if measurements are 'normal' or 'abnormal' — instead, they show where your child's measurements fit within the statistical distribution of children their age and gender. Healthcare professionals plot your child's height, weight, and head circumference (for babies) on these charts during routine check-ups. The charts include several important features: BMI Centile Lookup: Modern UK growth charts include Body Mass Index calculations that account for a child's age and gender, providing more accurate assessments than simple height-to-weight ratios. Adult Height Predictor: Advanced charts can estimate a child's potential adult height based on current growth patterns and parental heights. Mid-Parental Height Comparator: This feature compares a child's growth against their genetic potential based on both parents' heights. Puberty Guidance: Charts for older children include guidance on the onset and progression of puberty, helping identify early or delayed development. Understanding centile results can initially seem complex, but the system is designed to be intuitive once you grasp the basics. Here's what you need to know: Healthy Weight Ranges: According to NHS guidelines, a healthy weight result falls between the 3rd and 91st centile. This means that 88% of children fall within this range, representing normal variation in healthy growth patterns. The 50th Centile Myth: Many parents assume their child should be at the 50th centile (the average), but this is a common misconception. A child at the 10th centile is just as healthy as one at the 75th centile, provided they're growing consistently along their curve. Growth Patterns Matter More Than Single Measurements: Healthcare professionals look for consistent growth patterns rather than focusing on individual measurements. A child who consistently tracks along the 25th centile is typically healthier than one whose measurements jump dramatically between centiles. Normal Variation Range: Approximately 99% of children with healthy growth and development fall between the 0.4th and 99.6th centile. Children outside this range require assessment, though many factors can contribute to measurements outside typical ranges. BMI Considerations: For children and teenagers, BMI is given as a centile because young people are still growing. The NHS BMI calculator takes into account age, sex, height, and weight to provide accurate assessments. While growth charts are excellent monitoring tools, certain situations warrant professional medical attention: Measurements Below the 0.4th Centile: Children whose height falls below the 0.4th centile (less than 2 standard deviations below the mean) may have short stature that requires evaluation. However, many cases represent normal physiological variations such as familial short stature or constitutional growth delay. Crossing Multiple Centile Lines: If your child's growth pattern suddenly changes and crosses two or more centile lines (either upward or downward), this may indicate an underlying issue requiring assessment. Extreme BMI Measurements: Children with BMI measurements consistently above the 91st centile or below the 3rd centile should be evaluated by healthcare professionals. Concerning Symptoms: Seek medical advice if growth concerns are accompanied by other symptoms such as poor appetite, excessive fatigue, delayed development, or other health issues. Parental Concerns: Trust your instincts as a parent. If you're worried about your child's growth despite normal chart results, discuss your concerns with your GP or health visitor. Modern Child Growth Chart Calculator UK tools make it easier than ever for parents to monitor their children's development between healthcare appointments. These calculators use the same WHO standards and NHS guidelines that healthcare professionals rely on, providing accurate assessments you can trust. When choosing a Child Growth Chart Calculator UK, ensure it: Uses current WHO/NHS standards Accounts for your child's exact age and gender Provides centile results rather than simple 'normal/abnormal' classifications Includes guidance on interpreting results The best Child Growth Chart Calculator UK systems integrate multiple measurement parameters including height, weight, BMI, and head circumference for comprehensive growth assessment. Avoid Over-Monitoring: While growth tracking is valuable, avoid weighing or measuring your child too frequently. Daily fluctuations are normal and can cause unnecessary anxiety for both parents and children. Individual Variations: Remember that every child grows at their own pace. Siblings may have completely different growth patterns while both being perfectly healthy. Nutritional Factors: Breastfeeding, family dietary habits, and overall nutrition can influence growth patterns. The WHO standards are based on optimal growth conditions for breastfed infants. Genetic Factors: Family history plays a significant role in growth patterns. Children often follow growth trajectories similar to their parents. Premature Birth Considerations: For babies born prematurely, healthcare professionals may use adjusted ages for the first few years to account for early birth. Healthcare professionals use growth charts as part of comprehensive assessments that include: Physical examinations Developmental milestone assessments Family history reviews Nutritional evaluations When necessary, additional testing or referrals to specialists The UK's systematic approach to growth monitoring, combining WHO standards with NHS protocols, ensures that children receive appropriate care while avoiding unnecessary interventions for normal growth variations. Regular monitoring through your child's routine health checks, combined with occasional use of a reliable Child Growth Chart Calculator UK, provides the best approach to ensuring healthy development. When in doubt, always consult with your GP, health visitor, or pediatrician who can provide personalized guidance based on your child's complete health picture. Remember, Child Growth Chart Calculator UK tools are designed for tracking patterns over time rather than defining what's 'normal' for every child. Every child is unique, and healthy growth comes in many different forms. TIME BUSINESS NEWS

USA Today
16 hours ago
- USA Today
As new variant spreads, what's the latest COVID-19 vaccine guidance? It's complicated.
As a new COVID-19 variant takes over in the U.S., guidance surrounding vaccines has become increasingly confusing. Changes in vaccination guidelines, ever-evolving variants and strains, along with threats to health insurance, have sent average Americans looking for the latest recommendations as members of the federal government often conflict with independent medical agencies and healthcare professionals. In the two weeks leading up to June 21, the Centers for Disease Control and Prevention (CDC) reported just shy of 14,500 positive COVID tests, and while hospitalizations and deaths are fortunately down significantly since the pandemic's peak, vulnerable people are still grappling with limiting their risk amid changing practices. Having trouble keeping track of variants and vaccines? Here's what we know. What is the new NB.1.8.1 COVID variant? NB.1.8.1 is one of the latest variants of COVID-19, a "slightly upgraded version" of the LP.8.1 variant that is prominent right now, Subhash Verma, microbiology and immunology professor at the University of Nevada, Reno, previously told USA TODAY in May. Verma previously stated that NB.1.8.1 may be transferred more easily than LP.8.1. Additionally, he noted that NB.1.8.1 can evade antibodies created by vaccines or past infections more easily than LP.8.1. In early April, NB.1.8.1 accounted for 0% of COVID cases in the U.S. In the two weeks ending June 21, it accounted for the majority of cases at 43%, according to the CDC. The variant has similar symptoms to other strains, including fever or chills, cough, shortness of breath or difficulty breathing, sore throat, congestion or a runny nose, new loss of taste or smell, fatigue, muscle or body aches, headache, nausea or vomiting. One of its more unique features is "razor blade throat," reported by patients as an exceptionally sore throat. RFK and HHS change COVID vaccine guidance Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. said on May 27 that the COVID-19 vaccine would no longer be included in the CDC's recommended immunization schedule for healthy children and pregnant women, a move that broke with previous expert guidance and bypassed the normal scientific review process. Under the changes, the only people who will be recommended for COVID-19 vaccines are those over 65 and people with existing health problems. This could make it harder for others who want the COVID-19 vaccine to get it, including health care workers and healthy people under 65 with a vulnerable family member or those who want to reduce their short-term risk of infection. The American College of Obstetricians and Gynecologists (ACOG) and American Academy of Pediatrics (AAP), among other organizations, issued statements condemning the change, with the ACOG saying it was "...concerned about and extremely disappointed by the announcement that HHS will no longer recommend COVID-19 vaccination during pregnancy." "It is very clear that COVID-19 infection during pregnancy can be catastrophic and lead to major disability, and it can cause devastating consequences for families. The COVID-19 vaccine is safe during pregnancy, and vaccination can protect our patients and their infants after birth," President Steven J. Fleischman said in a statement. Insurance coverage typically follows federal recommendations, so anyone who is healthy and under 65 is likely to have to pay out of pocket to get the shot, which runs about $200, if they can get it. It's not clear what insurance companies will do about the new recommendations. AMA, AAP other organizations break from RFK and HHS on vaccines The American Medical Association (AMA) and American Academy of Pediatrics (AAP), in partnership with other professional medical organizations, broke from RFK and HHS after this announcement, sharing plans to develop their own guidelines independent of the government organization. In an open letter signed by 80 medical organizations across the country and published on June 25, the AMA called for physicians, healthcare networks and insurance companies to continue supporting "evidence-based immunizations to help prevent severe disease and protect public health." "Vaccines for influenza, RSV, and COVID-19 remain among the best tools to protect the public against these illnesses and their potentially serious complications—and physicians are among the most trusted voices to recommend them. We come together as physicians from every corner of medicine to reaffirm our commitment to these lifesaving vaccines," the letter said. "Recent changes to federal immunization review processes raised concerns across the medical and public health community. In this moment of uncertainty, physicians must align around clear, evidence-based guidance for patients." The AAP likewise said in a June 26 statement that it will "continue to publish its own evidence-based recommendations and schedules." AAP President Susan J. Kressly said the creation of federal immunization policy is 'no longer a credible process," adding, "...we're not stepping back, we're stepping up. The AAP will continue to publish our own immunization schedule just as we always have, developed by experts, guided by science, trusted by pediatricians and families across the country.' These latest independent guidelines have yet to be released. Vaccine committee adjourns without fresh recommendations Meanwhile, the new Advisory Committee on Immunization Practices (ACIP) gathered for the first time on June 25 in a meeting that drew criticism from some experts. RFK fired all 17 original members of the committee on June 9, replacing them with members that critics have called unqualified. Some of the members, like Kennedy, have a history of anti-vaccine advocacy, prompting backlash that had doctors and organizations calling for a delay in the meeting. Anti-vaccine sentiments were repeated by ACIP Chair Martin Kulldorf at the meeting, who said the panel will be "investigating" MMR and childhood vaccines. The CDC panel also reviewed data about COVID-19 vaccines, questioning their safety and effectiveness. They also raised questions about the study design, methodologies and surveillance monitoring systems behind the data, which Dr. Pamela Rockwell, clinical professor of family medicine at the University of Michigan Medical School, addressed as a standard of medical research. "Our efforts, through a very robust system of checks and balances, are to create vaccines and vaccination programs that result in the most benefit with the least harm," said Dr. Gretchen LaSalle, a family physician in Spokane, Washington, who represented the American Academy of Family Physicians. Despite this, the committee didn't vote on COVID-19 vaccine recommendations for the fall and isn't expected to reconvene until 'September/October,' according to the CDC website. ACIP commitee: Inside the unusual, RFK-appointed panel that's deciding on childhood vaccines FDA updates warning label for COVID vaccines The FDA likewise announced updated requirements for mRNA COVID-19 vaccine warning labels on June 25, which apply to Comirnaty by Pfizer Inc. and Spikevax by ModernaTX Inc. Prescribing information will now include warnings of the connection between the vaccines and a rare side effect that causes inflammation of the heart muscle and lining. The new warning label discloses the risk of myocarditis, which appeared in 8 cases per 1 million people who got the 2023-2024 COVID shots between the ages of 6 months and 64 years old, mostly commonly among males aged 12 to 24. The previous label, which also disclosed the risk, said the problem mostly occurred in minors aged 12-17. So, how do you protect yourself from NB.1.8.1 and other variants? Despite the back-and-forth in the U.S., the World Health Organization (WHO) has kept its recommendation consistent. Currently approved COVID-19 vaccines are expected to remain effective against the NB.1.8.1 variant, it said. In a webpage dated Jan. 7, the CDC advised that everyone over the age of six months get the 2024-2025 COVID-19 vaccine, specifically the 2024-2025 Moderna COVID-19 Vaccine. The page has since been updated with a banner, reading "COVID-19 vaccine recommendations have recently been updated for some populations. This page will be updated to align with the updated immunization schedule." The original recommendations align with the WHO's current guidelines. WHO, AMA, AAP and existing standards recommend that people who have never received a COVID-19 vaccine, are age 65 and older, are immunocompromised, live at a long-term care facility, are pregnant, breastfeeding, trying to get pregnant, and/or want to avoid getting long COVID, should get the vaccine, especially. Contributing: Greta Cross, Adrianna Rodriguez, USA TODAY


Time Business News
16 hours ago
- Time Business News
Why Every Household Needs Child-Resistant Containers - Safety First!
In a world where convenience and safety must go hand in hand, child-resistant containers have become a non-negotiable part of responsible product packaging. From medications and cleaning supplies to cannabis edibles and vitamins, these containers help protect children from accidental ingestion of potentially harmful substances. For every parent, caregiver, or responsible adult, the message is clear: safety starts with storage. Among the most effective and innovative options available today is the ROUND CR TIN-B, a sleek, tamper-resistant container designed to be both practical for adults and secure against curious little hands. This article explores why every household needs child-resistant containers, how they work, and why the ROUND CR TIN-B is becoming the go-to solution for modern families and businesses alike. Child-resistant containers (CRCs) are specifically designed to prevent children—especially those under five years old—from opening them easily. These packaging solutions use locking mechanisms, push-and-turn caps, and other design features that require a level of coordination and strength not typically possessed by young children. They are regulated in many parts of the world and are widely used to store: Prescription medications Over-the-counter drugs Cannabis products Household cleaning supplies Dietary supplements and vitamins Chemicals like pesticides and paints According to the World Health Organization (WHO) and other safety agencies, accidental poisoning is one of the top causes of injury-related deaths in children under five. Many of these accidents happen at home, where a moment of inattention can lead to tragedy. Here's why child-resistant packaging, like the ROUND CR TIN-B, is no longer optional: Increased Access to Pharmaceuticals & Supplements With more families keeping medications and supplements at home due to online pharmacy access and over-the-counter availability, the risk of accidental ingestion has grown. Cannabis Legalization As cannabis products become legal in more regions, households now store edibles, oils, and capsules—many of which look like regular snacks. Without child-resistant packaging, this can be extremely dangerous. Rise in DIY Products and Cleaners Many people store potent homemade cleaners and essential oils in non-secure containers, forgetting that child-proofing is essential even for 'natural' products. The ROUND CR TIN-B is not your typical child-proof container. It's a thoughtfully engineered, round, tin-based packaging solution with child-resistant features that align with both safety regulations and modern aesthetics. Here's what makes it a standout: This patented system ensures that opening the container requires both strength and dexterity—difficult for a child, but easy for an adult. Made from high-quality metal that meets food-grade safety standards, the ROUND CR TIN-B is perfect for storing a variety of substances safely. It supports full-color printing, embossing, and branding—ideal for cannabis brands, supplement companies, or health product lines looking to stand out. Unlike single-use plastic containers, the ROUND CR TIN-B is built to last. It's recyclable and designed for long-term use, reducing environmental waste. Its minimalist design makes it easy to store, while also offering a premium look that fits well in any modern home. Whether it's painkillers, prescription drugs, or vitamins, the ROUND CR TIN-B ensures these items are not easily accessed by children. Cannabis-infused gummies or chocolates often look like regular snacks. The ROUND CR TIN-B helps prevent confusing these with actual treats while complying with cannabis packaging regulations. Natural doesn't mean safe—many essential oils can be harmful if ingested. Using child-resistant containers for homemade remedies is crucial. Small batches of potent homemade or concentrated cleaners can be safely stored in the ROUND CR TIN-B to avoid accidents in the laundry room or kitchen. Child-resistant containers employ mechanisms that require multiple coordinated actions to open. Most common include: Push-and-turn caps Squeeze-and-pull lids Align-and-open systems (like the ROUND CR TIN-B) These designs are evaluated and tested to meet regulatory standards like the U.S. Poison Prevention Packaging Act (PPPA). Products like the ROUND CR TIN-B go beyond compliance—they innovate on design to ensure both usability and security. While the primary purpose of CRCs is to keep children safe, the ROUND CR TIN-B offers many additional benefits: For businesses, using high-quality child-resistant packaging shows care and compliance, boosting brand credibility. Reusable tins reduce single-use plastic waste and are easy to recycle, aligning with eco-conscious consumer values. Gone are the days of ugly, clunky medicine bottles. The ROUND CR TIN-B adds elegance to your shelves while doing its job behind the scenes. Once the original contents are used up, the tins can be repurposed for storing small items like paper clips, jewelry, or coins. For safety-first households, the ROUND CR TIN-B helps ensure medications and other hazardous items are kept secure from little hands. If your brand produces CBD, essential oils, supplements, or vitamins, this container offers a great combination of safety, quality, and aesthetics. Made from metal and reusable for years, these containers support a low-waste lifestyle. Selling high-value goods? The ROUND CR TIN-B provides an added level of protection and luxury for your packaging. Child safety in the home is about more than outlet covers and corner bumpers. It's about making smart, everyday decisions—like how you store potentially harmful products. Child-resistant containers are not just for industrial use or big brands—they're a practical necessity for every household. The ROUND CR TIN-B stands out in a sea of ordinary packaging options by combining child-resistance, sustainability, and style. Whether you're a parent, a brand owner, or simply someone who values safety, these containers represent a simple but effective way to protect what matters most. TIME BUSINESS NEWS